U.S. Healthcare Services Stock News

Q1 2026 results in focus SolarEdge Technologies (SEDG) opened 2026 with Q1 revenue of US$310.5 million and a basic EPS loss of US$0.94, alongside trailing twelve month revenue of US$1.28 billion and a basic EPS loss of US$5.99. Over recent quarters the company has seen revenue move from US$196.2 million in Q4 2024 to between roughly US$219.5 million and US$340.2 million through 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.84 to a loss of US$5.00, setting up...

If you are wondering whether Fortrea Holdings at US$15.64 is still offering value after a strong run, or if you are late to the story, this article focuses on what the current price might be implying. The stock has moved sharply, with returns of 48.1% over the last 7 days, 73.6% over the last 30 days and 177.8% over the last year, although year to date it sits at a 7.0% decline. Recent market attention has centered on Fortrea's position within the life sciences and pharmaceutical services...

Investors may be wondering whether Curtiss-Wright still offers good value after a strong share price performance, or if the current price has moved ahead of what the underlying business might justify. The stock last closed at US$742.89, with returns of 6.7% over 7 days, 6.3% over 30 days, 29.8% year to date and 105.5% over 1 year. These figures naturally raise questions about how much of the company’s story may already be reflected in the price. Recent attention on Curtiss-Wright has...

Ichor Holdings (ICHR) opened Q1 2026 with revenue of US$256.1 million and a basic EPS loss of US$0.07, alongside a trailing 12 month basic EPS loss of US$1.47 on revenue of US$959.3 million. Over recent quarters, the company has seen revenue move from US$244.5 million and a basic EPS loss of US$0.13 in Q1 2025 to US$223.6 million with a basic EPS loss of US$0.46 in Q4 2025, setting up this latest print as part of a wider stretch of loss making results. For investors, the key question now is...

Arrow International issued a nationwide recall of certain dialysis catheter kits that include Merit Medical’s 16F Dual-Valved Splittable Sheath Introducers. The recall is linked to a design defect that may prevent the sheath from splitting as intended during use. The action centers on product quality and regulatory compliance risks that could affect NasdaqGS:MMSI. Merit Medical Systems (NasdaqGS:MMSI) supplies devices used across interventional cardiology, radiology, and vascular access,...

The United States market has seen a robust performance, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to capitalize on undervalued assets.

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking undiscovered gems.

The United States market has experienced a robust performance recently, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, dividend stocks can be an attractive option for investors seeking steady income and potential growth, as they offer regular payouts while benefiting from the overall market's upward momentum.

For investors wondering if Abercrombie & Fitch is still good value after its recent run and subsequent pullbacks, this piece breaks down what the current share price might be implying about the stock. The stock last closed at US$79.40, with returns of 14.0% over the past year. Shorter-term moves include a 5.6% decline over 7 days, an 18.5% decline over 30 days, and a 35.8% decline year to date. Recent price action has put extra attention on whether earlier gains are fully justified or if the...

Investors may be wondering if Newmark Group at around US$16.60 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock has returned 5.3% over the past week and 13.2% over the past month, while the 1 year return sits at 49.7% and the 3 year return is a very large multiple, with a 5 year return of 36.3%. This means recent moves come on top of a sizeable longer term track record. Recent coverage around Newmark Group has focused on its...

In late April 2026, CBRE Group reported first-quarter 2026 results showing higher sales and net income than a year earlier, completed a long-running share buyback program totaling US$4.73 billion, and priced a US$750 million senior notes offering mainly to repay commercial paper borrowings. Together, these moves highlight CBRE’s focus on strengthening its balance sheet while returning capital to shareholders, underpinned by growing contributions from infrastructure and outsourcing-related...

Solstice Advanced Materials reported first-quarter 2026 results with net sales rising to US$991 million from US$897 million a year earlier, while net income declined to US$85 million from US$134 million, and the board affirmed a quarterly dividend of US$0.075 per share payable on June 10, 2026. The results highlight how Solstice’s role across AI cooling, nuclear fuel conversion, and semiconductor materials is becoming increasingly central even as reported earnings lag top-line...

U.S. authorities are increasing scrutiny of Smithfield Foods' foreign ownership ties, focusing on its Chinese parent and U.S. farmland holdings. National security reviews are expanding to foreign-owned agricultural land, especially near sensitive sites, putting Smithfield Foods' property footprint under closer review. These developments introduce fresh policy and perception risks for Smithfield Foods, which have not been reflected in earlier coverage. For investors tracking NasdaqGS:SFD,...

If you are trying to work out whether ACADIA Pharmaceuticals at around US$21.48 is attractively priced or not, the key question is what you are really getting for that price. The stock is currently around 18.3% lower year to date, yet it has returned 45.0% over the last year, a mix that can change how the market is thinking about both potential and risk. Recent news flow around ACADIA Pharmaceuticals has largely focused on its position in the pharmaceuticals and biotech space and how...

International Flavors & Fragrances (IFF) opened 2026 with Q1 revenue of US$2,741 million and basic EPS of US$0.66, setting a cleaner earnings picture after a volatile run of prior quarters. The company has seen quarterly revenue move from US$2,843 million and basic EPS of a US$3.98 loss in Q1 2025 to US$2,741 million and basic EPS of US$0.66 in Q1 2026. The trailing twelve month basic EPS is US$3.23 on revenue of US$10.8b. For investors, the key takeaway is that margins now look more...

In late April 2026, Equity Residential reported first-quarter revenue of US$779.85 million with net income of US$90.08 million, and issued second-quarter and full-year 2026 EPS-diluted guidance ranges of US$0.28–US$0.32 and US$1.28–US$1.40 respectively. Over the same period, the company also continued its long-running buyback program, repurchasing 3,458,394 shares for US$219.33 million and bringing total repurchases under the 2005 authorization to 287,109,423 shares for US$1.82 billion,...

Q1 2026 results and how they frame the story Apollo Global Management (APO) opened 2026 with Q1 revenue of about US$5.0b and a basic EPS loss of US$3.24, as net income excluding extra items came in at a loss of US$1.93b. The company has seen quarterly revenue move from US$5.49b and EPS of US$0.68 in Q1 2025 to a Q4 2025 peak of US$9.79b and EPS of US$1.44 before this latest quarter. Trailing 12 month EPS sits at US$1.95 on net income of US$1.16b from revenue of US$31.29b. This mix of headline...

Pitney Bowes (PBI) has opened 2026 with Q1 revenue of US$477.4 million and basic EPS of US$0.40, while its trailing twelve month figures stand at US$1.9 billion in revenue and basic EPS of about US$1.04, setting a clear baseline for how the business is currently performing. Over recent quarters, the company has seen revenue move from US$493.4 million in Q1 2025 to US$477.4 million in Q1 2026, with basic EPS shifting from roughly US$0.19 to US$0.40. Investors are likely to focus on how these...

Joby Aviation (JOBY) opened 2026 with Q1 revenue of US$24.2 million, a basic EPS loss of US$0.12, and a net income loss of US$110.0 million. This provides a clear snapshot of where the business currently stands on growth versus profitability. The company’s quarterly revenue moved from US$0.0 million in Q1 2025 to US$24.2 million in Q1 2026, while quarterly basic EPS over the same period ranged from a loss of US$0.11 to a loss of US$0.48. This leaves investors focused on how quickly margins...

In April 2026, USA Rare Earth announced that directors Mordechai Gutnick and General Paul Kern would not stand for reelection at the June 3 annual meeting, prompting the board to reduce its size to six members, while emphasizing that their decisions were not due to disagreements over the company’s operations or strategy. This board transition comes shortly after USA Rare Earth secured a US$1.60 billion US government-backed funding package and advanced its vertically integrated rare earth...

If you are wondering whether Harley-Davidson at around US$23.84 is a bargain or fairly priced, the key is understanding what the current share price actually reflects. The stock has returned 0.9% over the last week, 13.5% over the past month and 15.5% year to date, while the 1 year return sits at 7.1% and the 3 and 5 year returns are negative at 24.9% and 41.3% respectively. Taken together, this gives you a mixed picture of recent momentum and past shareholder experience. Recent headlines...

If you are wondering whether Rhythm Pharmaceuticals at US$96.61 is still a sensible entry or addition to your portfolio after a strong run, this article focuses squarely on what the current price may or may not reflect about value. The stock has moved sharply in the short term, with a 17.6% return over the last week and 11.1% over the last month. Year to date it is down 8.0% and the 1 year return sits at 49.5%. Over the last three years the stock return is very large, and over five years it...